PAA
BLUE

Peregrine Asset Advisers’s bluebird bio BLUE Stock Holding History

Peregrine Asset Advisers’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,087
Closed -$2.21M – 103
2019
Q2 		$2.21M Hold
1,087
– – 1.15% 38
2019
Q1 		$2.21M Buy
+1,087
New +$1.91M 1.28% 34
2017
Q3 		– Sell
-648
Closed -$881K – 89
2017
Q2 		$881K Buy
+648
New +$782K 0.56% 34

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Peregrine Asset Advisers's BLUE Position: Q3 2019 in Review

Peregrine Asset Advisers sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 1,087 shares — an estimated $2.21M sold.

Peregrine Asset Advisers first reported a position in BLUE in Q2 2017 and held it in 3 quarters. The position peaked at $2.21M in Q2 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Peregrine Asset Advisers reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Peregrine Asset Advisers sold 1,087 bluebird bio shares in Q3 2019, an estimated $2.21M.
  • Peregrine Asset Advisers first reported a position in bluebird bio in Q2 2017 and held it in 3 quarters.
  • Peregrine Asset Advisers's bluebird bio position peaked at $2.21M in Q2 2019.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Peregrine Asset Advisers's 13F filing for Q3 2019, filed 12 Nov 2019.